Table 1

Demographic characteristics

	MI patients (n=221)	MACE at 12 months (n=31)	No MACE at 12 months (n=190)	*P value
Age, year *Sex* Male, % (n) Female, % (n) Systolic BP, mmHg Diastolic BP, mmHg BMI, kg/m² Creatinin, µmol/L cTnI, ng/mL CRP, mg/L NT-proBNP, pg/ml LVEF, % Total CK, IU/L STEMI, % (n) NSTEMI, % (n) MACE rate, % (n) MACE details, % (n): -Deaths -Heart Failure related hospitalisations -Non fatal ACS -Non fatal stroke *Comorbidities, % (n)* Hypertension Diabetes Dyslipidaemia Smoker Obesity Known CAD Stroke Positive familial history Atrial fibrillation *Auto-Antibodies* Anti-apoA-1 IgG, Index Anti-HSP-60 antibodies, ng/ml Anti-β₂GPI IgG, GPL units Anti-βGPI IgM, GPL units Anti-βGPI IgA, GPL units Anti-cardiolipin IgG, GPL units Anti-cardiolipin IgM, GPL units Anti-cardiolipin IgA, GPL units Anti-β₂GPI D4D5 IgA, GPL units Anti-PC IgM, U/ml	64 (55–74) 78 (173) 22 (48) 120 (110-130) 70 (60-80) 25.8 (24–29) 84 (73–98) 0.50 (5–7) 6.0 (2.85-14) 785 (283-2057) 50 (45-55) 687 (273-1873) 54 (120) 46 (101) 14 (31) 1 (3) 4 (9) 9 (19) 0 (0) 53 (117) 19 (43) 46 (102) 45 (99) 16 (35) 29 (65) 5 (12) 31 (69) 5 (11) 22.2 (15.9-31.3) 18.5 (11.5-37.1) 1.1 (0.9-1.3) 2.1 (1.3-3.5) 4.5 (3.5-6.1) 3.6 (2.4-5.4) 3.9 (2.5-5.7) 2.7 (1.9-4.1) 7.3 (4.9-10.4) 33.1 (22.5-55.2)	67 (55-80) 90 (28) 10 (3) 120 (100-130) 70 (60-80) 26.5 (24.5-29.5) 95 (77-114) 0.84 (0.10-3.42) 10.9 (3-31.4) 1503 (475-3500) 45 (35-50) 509 (264-1168) 43 (13) 58 (18) - - - - - 51 (18) 32 (10) 42 (13) 23 (7) 23 (7) 52 (16) 13 (4) 29 (9) 13 (4) 31.4 (20.7-41.2) 22.5 (15.6-43) 1.1 (1.0-1.4) 2.4 (1.2-3.6) 4.8 (3.5-6.5) 4.4 (6.2-2.6) 4.0 (3.0-7.2) 3.2 (1.7-4.9) 7.8 (5.6-11.1) 37.9 (17-45.9)	63 (55-74) 76 (145) 24 (45) 120 (110-130) 70 (60-80) 25.8 (23.7-28.4) 83 (72-96) 0.38 (0.09-2.98) 5.9 (2.7-13) 771 (271-1641) 50 (45-60) 703 (280-1818) 56 (107) 44 (83) - - - - - 52 (99) 17 (33) 47 (89) 5 (9) 15 (28) 26 (49) 4 (8) 32 (60) 4 (7) 20.6 (15.5-29.9) 17.8 (11.2-36.5) 1.0 (0.9-1.3) 2.1 (1.3-3.4) 4.5 (3.5-6.1) 3.5 (2.4-5.4) 3.9 (2.5-5.7) 2.7 (1.9-4.0) 7.2 (4.8-10.4) 32.8 (22.9-57.8)	0.43 0.10 0.52 0.93 0.18 0.01 0.36 0.11 0.07 0.0003 0.49 0.17 - - - - - - 0.56 0.08 0.70 0.003 0.29 0.005 0.06 0.84 0.06 0.009 0.14 0.46 0.82 0.58 0.17 0.12 0.50 0.38 0.73

Table 1: All continuous variables are reported as median with interquartile range. *P-value was calculated according to Mann–Whitney U-test for continuous variable and according to exact bilateral Fischer test for proportions. P values were computed by comparing groups of patients with and without MACE during the follow-up.